(Q34094620)

31 July 2017

0 references

Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis (English)

1 reference

31 July 2017

0 references

0 references

0 references

Pramodini B Kale-Pradhan

series ordinal

1

1 reference

31 July 2017

Harjot K Jassal

series ordinal

2

1 reference

31 July 2017

Sheila M Wilhelm

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

30

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

119-126

1 reference

Clinical practice. Antibiotic-associated diarrhea

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Treatment and prevention of antibiotic associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Mechanisms and management of antibiotic-associated diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Epidemiology, risk factors and treatments for antibiotic-associated diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Review of current literature on the economic burden of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Effect of a lactobacillus preparation on the absorption of oral ampicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

In vitro growth control of selected pathogens by Lactobacillus acidophilus- and Lactobacillus casei-fermented milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.119

21 January 2018

Identifiers

DOI

10.1592/PHCO.30.2.119

1 reference

31 July 2017

1 reference